1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PIANP CTRPv2 pan-cancer AAC 0.22 3e-08
mRNA LRRC37B CTRPv2 pan-cancer AAC 0.19 3e-08
mRNA PAXIP1 CTRPv2 pan-cancer AAC 0.19 3e-08
mRNA CBX2 CTRPv2 pan-cancer AAC 0.2 3e-08
mRNA PIAS2 CTRPv2 pan-cancer AAC 0.19 3e-08
mRNA RNF138 CTRPv2 pan-cancer AAC 0.2 3e-08
mRNA ADAM22 CTRPv2 pan-cancer AAC 0.2 4e-08
mRNA CNOT9 CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA SNRNP70 CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA SEMA6C CTRPv2 pan-cancer AAC 0.18 4e-08
Download CSV